The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The Power of Power Doppler: Ultrasound Imaging in RA

The Power of Power Doppler: Ultrasound Imaging in RA

March 23, 2022 • By Jason Liebowitz, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

BALTIMORE—Rheumatology is a field in which all data points are considered in building the case for a patient’s diagnosis and seeking to clarify disease activity and prognosis. In recent years, information gleaned through ultrasound imaging has helped supplement the data gathered from the traditional history, physical exam, and laboratory and radiographic studies alone.

You Might Also Like
  • Whole-Body MRI, Ultrasound Imaging May Aid in Early Rheumatic Disease Diagnosis, Treatment
  • According to MRI, Ultrasound Guidance Does Not Improve Treat-to-Target in RA
  • Predictive Value of Whole-Body MRI & Ultrasound Explored in EULAR Studies
Explore This Issue
April 2022
Also By This Author
  • Check It Out: Understanding Immune-Related Adverse Events from Immune Checkpoint Inhibitors

At the 17th Annual Advances in the Diagnosis and Treatment of the Rheumatic Diseases meeting at Johns Hopkins University School of Medicine, Baltimore, Dana DiRenzo, MD, MHS, RhMSUS, instructor of medicine, Johns Hopkins University School of Medicine, provided an extremely helpful overview of the use of ultrasound imaging in patients with inflammatory arthritis.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Limitations of Traditional Examinations

Dr. DiRenzo began by noting some of the limitations of the traditional clinical examination in evaluating patients for rheumatoid arthritis (RA). Disease activity scores can sometimes be artificially elevated in patients with comorbidities that increase the tender joint count even in the absence of frank joint swelling, she explained. The issue of inter-observer variance of clinical joint assessments also arises, with different clinicians having different assessments of the presence or absence of synovitis in the same joint for a specific patient. More recently, a newfound appreciation has developed for the entity of “subclinical synovitis,” which may not be easily detectable on the clinical exam.

For the definition of terms for ultrasound findings, Dr. DiRenzo referenced the Outcome Measures in Rheumatology (OMERACT) group definitions for ultrasound-detected pathologies.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Synovitis is defined as the presence of a hypoechoic synovial hypertrophy regardless of the presence of effusion or any grade of Doppler signal.

The term erosion is defined as intra- and/or extra-articular discontinuity of bone surface that is visible in two perpendicular planes.1

Other helpful terms include gray scale, which is the modality used to detect lesions of synovial effusion and hypertrophy, and power Doppler, which is the modality used to detect blood flow to the synovial membrane.2

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Baseline Ultrasound Assessment

Ultrasound is used in rheumatology for diagnosis and disease monitoring. It can also assist in predicting prognosis, Dr. DiRenzo noted. With regard to diagnosis, Horton et al. evaluated 60 patients with new-onset undifferentiated arthritis who did not meet 2010 ACR/European League Against Rheumatism (EULAR) RA classification criteria.3 These patients underwent baseline ultrasound assessment and then were followed prospectively, with 22% ultimately meeting criteria for RA, and 53% (32 of the 60 patients) receiving methotrexate within 12 months after enrollment. The authors found that severity of gray scale synovitis detected across 26 joints was predictive of progression to RA and of methotrexate use, independent of the clinical swollen joint count or disease activity score.

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Meeting Reports, Rheumatoid Arthritis Tagged With: Advances in the Diagnosis and Treatment of the Rheumatic Diseases meeting, diagnostic imaging, imaging, RA Resource Center, Rheumatoid Arthritis (RA), UltrasoundIssue: April 2022

You Might Also Like:
  • Whole-Body MRI, Ultrasound Imaging May Aid in Early Rheumatic Disease Diagnosis, Treatment
  • According to MRI, Ultrasound Guidance Does Not Improve Treat-to-Target in RA
  • Predictive Value of Whole-Body MRI & Ultrasound Explored in EULAR Studies
  • EULAR 2015: Imaging in Rheumatology

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)